Solutions
- Care
  A turnkey solution delivering personalized care to acute, post-acute, and chronic patients with an integrated platform and dedicated remote care teams to reduce costs, readmissions, and healthcare use for payers and providers.
- Digital Medicine
  A holistic, end-to-end solution designed to augment drug efficacy with digital therapeutics, accelerate product innovation with digital biomarkers for pharmaceutical companies, and improve adherence and outcomes for patients.
Technology
Company
News & Resources
- Videos
- Press Releases

Solutions
- Care
  A turnkey solution delivering personalized care to acute, post-acute, and chronic patients with an integrated platform and dedicated remote care teams to reduce costs, readmissions, and healthcare use for payers and providers.
- Digital Medicine
  A holistic, end-to-end solution designed to augment drug efficacy with digital therapeutics, accelerate product innovation with digital biomarkers for pharmaceutical companies, and improve adherence and outcomes for patients.
Technology
Company
News & Resources
- Videos
- Press Releases

Thank You For Requesting a Demo

A Biofourmis team member will be in contact soon to schedule your demo. In the meantime, stay up-to-date with the latest Biofourmis news by following us on LinkedIn and Twitter.

What Our Customers Are Saying

“Through the partnership with Biofourmis, a leading company in research, development and commercialization of digital medicine, Chugai will set out to objectively assess pain associated with endometriosis and better understand its pathology.”

"The Everion^® biosensor has become part of my daily habit. I wear it and forget about it and I know a care team is always there to make sure I am safe."

"The goal of this program is to leverage Biovitals^® to remotely monitor patients and identify COVID-19 related physiological biomarkers that indicate deterioration in patients."

Previous

Next

Awards

Forbes AI 50 2020: America’s Most Promising Artificial Intelligence Companies

Forbes partnered with venture firms Sequoia Capital and Meritech Capital to create our second annual AI 50, a list of private, U.S.-based companies that are using artificial intelligence in meaningful business-oriented ways.

Biofourmis Wins Two 2021 Fierce Healthcare Innovation Awards for Hospital@Home Solution

A panel of judges looked for effectiveness, technical innovation, competitive advantage, financial impact and true innovation.

FierceHealthcare’s Fierce 15 Award in 2020

Since its founding in 2015, digital medicine and remote monitoring startup Biofourmis has been trying to figure out how to move healthcare beyond the pill.

Annual ranking of the 150 most promising digital health startups in the world

In 2019, digital health companies from 18 countries spanning 17 overarching categories were selected for the first-ever annual CB Insights Digital Health 150.

2021 DPHARM Idol Disrupt Winner

Biofourmis had to present their innovation and demonstrate how virtual care and digital medicine can disrupt clinical trials to an esteemed panel of judges, followed by a rigorous Q&A.

Kuldeep Singh Rajput named on Boston Business Journal 2021 40 Under 40

The Boston Business Journal announces 2021 40 Under 40, an award that celebrates the city’s best and brightest young professionals each year.

Accenture HealthTech Innovation Challenge 2021: Rising Star

UCSF Health Awards 2021: Quarterfinalist: Breakthrough COVID-19 Technology category

Citeline Awards 2021: Finalist: Excellence in Innovation in Response to COVID-19 — Healthcare and Diagnostics